Global Acute Ischemic Stroke Drugs Market Size, Status and Forecast 2019-2025

Code: QYRE-Auto-29M171

Report

October 2019

98 Pages

QYResearch

Region: Global, Europe, North America, Japan, China,

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Sanofi

Biogen

Bayer

Pfizer Inc

Roche

Boehringer Ingelheim

Daiichi Sankyo

Bristol–Myers Squibb

Johnson & Johnson

Astrazeneca plc

ZZ Biotech

NoNO Inc

Athersys

SanBio

Biogen Inc

Bayer AG

Sanofi S A

Acute Ischemic Stroke (CIS), also known as Cerebral Infarction (CI), is due to the occlusion of the Cerebral artery caused by the Infarction of brain tissue, accompanied by damage to neurons, astrocytes, oligodendrocytes, is the modern society leading to death and disability of the most important central nervous system vascular events.

In 2018, the global Acute Ischemic Stroke Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Acute Ischemic Stroke Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Ischemic Stroke Drugs development in North America, Europe, China and Japan.

The key players covered in this study

Sanofi

Biogen

Bayer

Pfizer

Roche

Boehringer Ingelheim

Daiichi Sankyo

Bristol-Myers Squibb

Johnson＆Johnson

AstraZeneca

ZZ Biotech

NoNO Inc

Athersys

SanBio

Market segment by Type, the product can be split into

Tablet

Capsule

Other

Market segment by Application, split into

Hospitals

Diagnostic Centers

Others

Market segment by Regions/Countries, this report covers

North America

Europe

China

Japan

The study objectives of this report are:

To analyze global Acute Ischemic Stroke Drugs status, future forecast, growth opportunity, key market and key players.

To present the Acute Ischemic Stroke Drugs development in North America, Europe, China and Japan.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Acute Ischemic Stroke Drugs are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered

FEATURED COMPANIES

Sanofi

Biogen

Bayer

Pfizer Inc

Roche

Boehringer Ingelheim

Daiichi Sankyo

Bristol–Myers Squibb

Johnson & Johnson

Astrazeneca plc

ZZ Biotech

NoNO Inc

Athersys

SanBio

Biogen Inc

Bayer AG

Sanofi S A

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Acute Ischemic Stroke Drugs Market Size Growth Rate by Type (2014-2025)

1.4.2 Tablet

1.4.3 Capsule

1.4.4 Other

1.5 Market by Application

1.5.1 Global Acute Ischemic Stroke Drugs Market Share by Application (2019-2025)

1.5.2 Hospitals

1.5.3 Diagnostic Centers

1.5.4 Others

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Acute Ischemic Stroke Drugs Market Size

2.2 Acute Ischemic Stroke Drugs Growth Trends by Regions

2.2.1 Acute Ischemic Stroke Drugs Market Size by Regions (2019-2025)

2.2.2 Acute Ischemic Stroke Drugs Market Share by Regions (2014-2019)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Challenges

2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

3.1 Acute Ischemic Stroke Drugs Market Size by by Players

3.1.1 Global Acute Ischemic Stroke Drugs Revenue by by Players (2014-2019)

3.1.2 Global Acute Ischemic Stroke Drugs Revenue Market Share by by Players (2014-2019)

3.1.3 Global Acute Ischemic Stroke Drugs Market Concentration Ratio (CR5 and HHI)

3.2 Acute Ischemic Stroke Drugs Key Players Head office and Area Served

3.3 Key Players Acute Ischemic Stroke Drugs Product/Solution/Service

3.4 Date of Enter into Acute Ischemic Stroke Drugs Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Acute Ischemic Stroke Drugs Market Size by Type (2014-2019)

4.2 Global Acute Ischemic Stroke Drugs Market Size by Application (2014-2019)

5 North America

5.1 North America Acute Ischemic Stroke Drugs Market Size (2014-2019)

5.2 Acute Ischemic Stroke Drugs Key Players in North America

5.3 North America Acute Ischemic Stroke Drugs Market Size by Type

5.4 North America Acute Ischemic Stroke Drugs Market Size by Application

6 Europe

6.1 Europe Acute Ischemic Stroke Drugs Market Size (2014-2019)

6.2 Acute Ischemic Stroke Drugs Key Players in Europe

6.3 Europe Acute Ischemic Stroke Drugs Market Size by Type

6.4 Europe Acute Ischemic Stroke Drugs Market Size by Application

7 China

7.1 China Acute Ischemic Stroke Drugs Market Size (2014-2019)

7.2 Acute Ischemic Stroke Drugs Key Players in China

7.3 China Acute Ischemic Stroke Drugs Market Size by Type

7.4 China Acute Ischemic Stroke Drugs Market Size by Application

8 Japan

8.1 Japan Acute Ischemic Stroke Drugs Market Size (2014-2019)

8.2 Acute Ischemic Stroke Drugs Key Players in Japan

8.3 Japan Acute Ischemic Stroke Drugs Market Size by Type

8.4 Japan Acute Ischemic Stroke Drugs Market Size by Application

9 International Players Profiles

9.1 Sanofi

9.1.1 Sanofi Company Details

9.1.2 Company Description and Business Overview

9.1.3 Acute Ischemic Stroke Drugs Introduction

9.1.4 Sanofi Revenue in Acute Ischemic Stroke Drugs Business (2014-2019))

9.1.5 Sanofi Recent Development

9.2 Biogen

9.2.1 Biogen Company Details

9.2.2 Company Description and Business Overview

9.2.3 Acute Ischemic Stroke Drugs Introduction

9.2.4 Biogen Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)

9.2.5 Biogen Recent Development

9.3 Bayer

9.3.1 Bayer Company Details

9.3.2 Company Description and Business Overview

9.3.3 Acute Ischemic Stroke Drugs Introduction

9.3.4 Bayer Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)

9.3.5 Bayer Recent Development

9.4 Pfizer

9.4.1 Pfizer Company Details

9.4.2 Company Description and Business Overview

9.4.3 Acute Ischemic Stroke Drugs Introduction

9.4.4 Pfizer Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)

9.4.5 Pfizer Recent Development

9.5 Roche

9.5.1 Roche Company Details

9.5.2 Company Description and Business Overview

9.5.3 Acute Ischemic Stroke Drugs Introduction

9.5.4 Roche Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)

9.5.5 Roche Recent Development

9.6 Boehringer Ingelheim

9.6.1 Boehringer Ingelheim Company Details

9.6.2 Company Description and Business Overview

9.6.3 Acute Ischemic Stroke Drugs Introduction

9.6.4 Boehringer Ingelheim Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)

9.6.5 Boehringer Ingelheim Recent Development

9.7 Daiichi Sankyo

9.7.1 Daiichi Sankyo Company Details

9.7.2 Company Description and Business Overview

9.7.3 Acute Ischemic Stroke Drugs Introduction

9.7.4 Daiichi Sankyo Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)

9.7.5 Daiichi Sankyo Recent Development

9.8 Bristol-Myers Squibb

9.8.1 Bristol-Myers Squibb Company Details

9.8.2 Company Description and Business Overview

9.8.3 Acute Ischemic Stroke Drugs Introduction

9.8.4 Bristol-Myers Squibb Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)

9.8.5 Bristol-Myers Squibb Recent Development

9.9 Johnson＆Johnson

9.9.1 Johnson＆Johnson Company Details

9.9.2 Company Description and Business Overview

9.9.3 Acute Ischemic Stroke Drugs Introduction

9.9.4 Johnson＆Johnson Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)

9.9.5 Johnson＆Johnson Recent Development

9.10 AstraZeneca

9.10.1 AstraZeneca Company Details

9.10.2 Company Description and Business Overview

9.10.3 Acute Ischemic Stroke Drugs Introduction

9.10.4 AstraZeneca Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)

9.10.5 AstraZeneca Recent Development

9.11 ZZ Biotech

9.12 NoNO Inc

9.13 Athersys

9.14 SanBio

10 Market Forecast 2019-2025

10.1 Market Size Forecast by Product (2019-2025)

10.2 Market Size Forecast by Application (2019-2025)

10.3 Market Size Forecast by Regions

10.4 North America

10.5 Europe

10.6 China

10.7 Japan

11 Analyst's Viewpoints/Conclusions

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Disclaimer

12.3 Author Detail

FEATURED COMPANIES

Sanofi

Biogen

Bayer

Pfizer Inc

Roche

Boehringer Ingelheim

Daiichi Sankyo

Bristol–Myers Squibb

Johnson & Johnson

Astrazeneca plc

ZZ Biotech

NoNO Inc

Athersys

SanBio

Biogen Inc

Bayer AG

Sanofi S A

List of Tables and Figures

Table Acute Ischemic Stroke Drugs Key Market Segments

Table Key Players Acute Ischemic Stroke Drugs Covered

Table Global Acute Ischemic Stroke Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)

Figuer Tablet Figures

Table Key Players of Tablet

Figuer Capsule Figures

Table Key Players of Capsule

Figuer Other Figures

Table Key Players of Other

Table Global Acute Ischemic Stroke Drugs Market Size Growth by Application 2019-2025 (Million US$)

Figure Global Acute Ischemic Stroke Drugs Market Share by Application in 2018 & 2025

Figure Hospitals Case Studies

Figure Diagnostic Centers Case Studies

Figure Others Case Studies

Figure Acute Ischemic Stroke Drugs Report Years Considered

Figure Global Acute Ischemic Stroke Drugs Market Size and Growth Rate 2014-2025 (Million US$)

Table Global Acute Ischemic Stroke Drugs Market Size by Regions 2019-2025 (Million US$)

Table Global Acute Ischemic Stroke Drugs Market Share by Regions 2014-2019

Figure Global Acute Ischemic Stroke Drugs Market Share by Regions 2014-2019

Figure Global Acute Ischemic Stroke Drugs Market Share by Regions in 2018

Table Market Top Trends

Table Key Drivers: Impact Analysis (2019-2025)

Table Key Challenges

Figure PORTER'S FIVE FORCES ANALYSIS

Table Global Acute Ischemic Stroke Drugs Revenue by by Players (2014-2019) (Million US$)

Table Global Acute Ischemic Stroke Drugs Market Share by by Players (2014-2019)

Figure Global Acute Ischemic Stroke Drugs Market Share by by Players in 2018

Table Global Acute Ischemic Stroke Drugs by Players Market Concentration Ratio (CR5 and HHI)

Table Key Players Head office and Area Served

Table Key Players Acute Ischemic Stroke Drugs Product/Solution/Service

Table Date of Enter into Acute Ischemic Stroke Drugs Market

Table Mergers & Acquisitions, Expansion Plans

Table Global Acute Ischemic Stroke Drugs Market Size by Type (2014-2019) (Million US$)

Table Global Acute Ischemic Stroke Drugs Market Size Share by Type (2014-2019)

Figure Global Acute Ischemic Stroke Drugs Market Size Market Share by Type (2014-2019)

Table Global Acute Ischemic Stroke Drugs Market Size by Application (2014-2019) (Million US$)

Table Global Acute Ischemic Stroke Drugs Market Size Share by Application (2014-2019)

Figure Global Acute Ischemic Stroke Drugs Market Size Market Share by Application (2014-2019)

Figure Global Acute Ischemic Stroke Drugs Revenue Market Share by Application in 2018

Figure North America Acute Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)

Table North America Key Players Acute Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)

Table North America Key Players Acute Ischemic Stroke Drugs Market Share (2018-2019)

Table North America Acute Ischemic Stroke Drugs Market Size by Type 2014-2019 (Million US$)

Table North America Acute Ischemic Stroke Drugs Market Share by Type 2014-2019

Table North America Acute Ischemic Stroke Drugs Market Size by Application 2014-2019 (Million US$)

Table North America Acute Ischemic Stroke Drugs Market Share by Application 2014-2019

Figure Europe Acute Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)

Table Europe Key Players Acute Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)

Table Europe Key Players Acute Ischemic Stroke Drugs Market Share (2018-2019)

Table Europe Acute Ischemic Stroke Drugs Market Size by Type 2014-2019 (Million US$)

Table Europe Acute Ischemic Stroke Drugs Market Share by Type 2014-2019

Table Europe Acute Ischemic Stroke Drugs Market Size by Application 2014-2019 (Million US$)

Table Europe Acute Ischemic Stroke Drugs Market Share by Application 2014-2019

Figure China Acute Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)

Table China Key Players Acute Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)

Table China Key Players Acute Ischemic Stroke Drugs Market Share (2018-2019)

Table China Acute Ischemic Stroke Drugs Market Size by Type 2014-2019 (Million US$)

Table China Acute Ischemic Stroke Drugs Market Share by Type 2014-2019

Table China Acute Ischemic Stroke Drugs Market Size by Application 2014-2019 (Million US$)

Table China Acute Ischemic Stroke Drugs Market Share by Application 2014-2019

Figure Japan Acute Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)

Table Japan Key Players Acute Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)

Table Japan Key Players Acute Ischemic Stroke Drugs Market Share (2018-2019)

Table Japan Acute Ischemic Stroke Drugs Market Size by Type 2014-2019 (Million US$)

Table Japan Acute Ischemic Stroke Drugs Market Share by Type 2014-2019

Table Japan Acute Ischemic Stroke Drugs Market Size by Application 2014-2019 (Million US$)

Table Japan Acute Ischemic Stroke Drugs Market Share by Application 2014-2019

Table Sanofi Company Details

Table Sanofi Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)

Figure Sanofi Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)

Table Sanofi Recent Development

Table Biogen Company Details

Table Biogen Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)

Figure Biogen Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)

Table Biogen Recent Development

Table Bayer Company Details

Table Bayer Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)

Figure Bayer Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)

Table Bayer Recent Development

Table Pfizer Company Details

Table Pfizer Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)

Figure Pfizer Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)

Table Pfizer Recent Development

Table Roche Company Details

Table Roche Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)

Figure Roche Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)

Table Roche Recent Development

Table Boehringer Ingelheim Company Details

Table Boehringer Ingelheim Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)

Figure Boehringer Ingelheim Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)

Table Boehringer Ingelheim Recent Development

Table Daiichi Sankyo Company Details

Table Daiichi Sankyo Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)

Figure Daiichi Sankyo Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)

Table Daiichi Sankyo Recent Development

Table Bristol-Myers Squibb Company Details

Table Bristol-Myers Squibb Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)

Figure Bristol-Myers Squibb Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)

Table Bristol-Myers Squibb Recent Development

Table Johnson＆Johnson Company Details

Table Johnson＆Johnson Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)

Figure Johnson＆Johnson Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)

Table Johnson＆Johnson Recent Development

Table AstraZeneca Company Details

Table AstraZeneca Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)

Figure AstraZeneca Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)

Table AstraZeneca Recent Development

Table ZZ Biotech Company Details

Table NoNO Inc Company Details

Table Athersys Company Details

Table SanBio Company Details

Table Global Acute Ischemic Stroke Drugs Market Size by Regions (Million US$) 2019-2025

Figure Global Acute Ischemic Stroke Drugs Market Size Share by Regions (2019-2025)

Figure Global Acute Ischemic Stroke Drugs Market Size Share by Regions in 2025

Figure North America Acute Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)

Figure Europe Acute Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)

Figure China Acute Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)

Figure Japan Acute Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)

Table Global Acute Ischemic Stroke Drugs Market Size by Product (2019-2025) (Million US$)

Figure Global Acute Ischemic Stroke Drugs Market Size by Product (2019-2025)

Figure Global Acute Ischemic Stroke Drugs Market Size by Product in 2025

Table Global Acute Ischemic Stroke Drugs Market Size by Application (2019-2025) (Million US$)

Figure Global Acute Ischemic Stroke Drugs Market Size by Application (2019-2025)

Figure Global Acute Ischemic Stroke Drugs Market Size by Application in 2025

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Source